- Latest available (Revised)
- Original (As made)
This version of this provision is prospective.
The term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section. A version of a provision is prospective either:
Commencement Orders listed in the ‘Changes to Legislation’ box as not yet applied may bring this prospective version into force.
The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025, Section 7 is up to date with all changes known to be in force on or before 03 August 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Prospective
7.—(1) Regulation 6 (establishment of ethics committees) is amended as follows.
(2) In the heading, after “establishment” insert “and abolition”.
(3) In paragraph (1)—
(a)for “ethics committees” substitute “an ethics committee”;
(b)omit sub-paragraph (a).
(4) After paragraph (1) insert—
“(1A) The Authority must ensure that the arrangements for the membership and operation of that committee—
(a)enable that committee to perform the functions of an ethics committee; and
(b)comply with regulation 9.”.
(5) For paragraph (2) substitute—
“(2) The Authority may—
(a)specify any conditions or limitations that apply to an ethics committee, including whether that committee may act for the entire United Kingdom or only for a particular area of the United Kingdom;
(b)where they consider it necessary or appropriate to do so—
(i)vary the description or class of clinical trial in relation to which that committee may act as an ethics committee, or
(ii)vary or revoke any conditions or limitations imposed under paragraph (2)(a); and
(c)abolish any such committee if the Authority is satisfied that—
(i)the arrangements for the membership and operation of that committee are no longer such that the committee is able to adequately perform its functions under these Regulations,
(ii)the committee is failing to perform its functions under these Regulations adequately or at all, or
(iii)it is otherwise necessary or appropriate to do so.”.
(6) After paragraph (2) insert—
“(3) Where the Authority abolishes an ethics committee or an ethics committee ceases operation—
(a)the Authority may nominate another committee to be responsible for the work of that committee;
(b)the committee nominated in accordance with sub-paragraph (a) must—
(i)consider any applications made to the old committee in accordance with regulation 15, if the old committee had not given an opinion before the date of abolition or ceasing of operation, and
(ii)be the relevant ethics committee for any clinical trial in relation to which the old committee had given a favourable opinion in accordance with regulation 18 or 18B.”.
Commencement Information
I1Reg. 7 in force at 28.4.2026, see reg. 1(2)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: